Target intelligence / Profile preview

Bacterial DNA and intracellular proteins

Molecular classification
Nucleic acid, Protein, Enzyme
01

Overview

Bacterial DNA and intracellular proteins represent a composite target for broad-spectrum antimicrobial agents, primarily antiseptics and heavy metals. This target includes the bacterial chromosome, which is essential for genetic inheritance and protein synthesis, and the cytoplasmic proteome, which encompasses all enzymes and structural proteins required for metabolism (PubMed: 16702442). Unlike targeted antibiotics that inhibit specific pathways, agents acting on these components often cause widespread damage by denaturing proteins and disrupting the integrity of nucleic acids (PubMed: 12673917). For instance, silver ions are known to bind to DNA bases and functional groups in proteins, leading to the cessation of cellular respiration and division (PubMed: 21034431). While highly effective at killing a wide range of pathogens, the lack of specificity often limits these agents to topical applications to avoid damage to human cells (PubMed: 15907336). This multi-target approach is particularly valuable in preventing the development of bacterial resistance, as simultaneous mutations in multiple essential components are highly unlikely.

Other names
Bacterial genome and proteomeIntracellular bacterial componentsBacterial cytoplasmic targetsBacterial nucleic acids and enzymes
02

Mechanism of action

Antimicrobial agents targeting these components typically act via non-specific mechanisms: silver ions bind to bacterial DNA, preventing replication, and interact with thiol groups on proteins, causing denaturation (PubMed: 21034431). Oxidizing agents like povidone-iodine oxidize essential cellular components, including proteins and nucleic acids, leading to rapid cell death (PubMed: 15907336).

03

Biological functions

DNA replicationTranscriptionTranslationMetabolismCellular homeostasisStructural integrity
04

Disease associations

Infection
05

Safety considerations

Cytotoxicity to mammalian cellsTissue irritationDelayed wound healingArgyria (associated with chronic silver exposure)Systemic toxicity if absorbed in large quantities
06

Interacting drugs

Silver sulfadiazine

5 more in the full profile.

07

Biomarkers

Bacterial colony forming units (CFU)C-reactive protein (CRP)Procalcitonin

Beyond the preview

Go deeper on Bacterial DNA and intracellular proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial DNA and intracellular proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call